If conserved in mammalian cells, one would assume that decreased levels of LIG4 in CML patients would result in destabilized Ku70 and in turn in increased end resection [78]. The gene discussed is LIG4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.